Coronary Disease/Myocardial Infarction
RSSArticles
-
Spironolactone for Heart Failure
-
The CORAL Trial: Is This the End for Renal Artery Stenting?
-
TAVR in the Real World: The Initial 18 months' Experience in the United States
-
New Study Advocates for More Provocative Vasospasm Testing During Routine Cardiac Catheterization
Since the initial description of variant angina by Prinzmetal in the late 1950s and the later confirmation of coronary artery spasm as its cause, clinicians have sought a means of reliably testing for this entity. -
Is Catheter Ablation Superior to Antiarrhythmic Drugs in Treating Premature Ventricular Contractions?
Frequent premature ventricular contractions (PVCs) may lead to a cardiomyopathy or worsen a pre-existing cardiomyopathy. -
Who Should be Referred for Advanced Heart Failure Care?
-
Value of the Physical Examination in Heart Failure
-
Should Catheter Ablation be First-Line Therapy for Patients with Paroxysmal AF?
Atrial fibrillation (AF) is common and catheter ablation has become widely available. -
The Allen’s Test Prior to Transradial Access: A Necessary Precaution or a Waste of Time?
The transradial approach to cardiac catheterization has been steadily gaining ground over the past several years due to advantages over the femoral approach in terms of bleeding risk, vascular injury, procedural cost, and patient comfort. -
Left Main Stenting
Stenosis of the left main coronary artery has traditionally been an indication for coronary artery bypass graft (CABG) surgery. However, recent studies have shown that percutaneous coronary intervention (PCI) of unprotected left main (ULM) lesions can achieve similar short- and medium-term results to CABG.